Gold prices are jumping higher, finding some new bullish momentum as fewer Americans-than-expected found work in November.
The 5 Best Values In Psychedelic Stocks
Psychedelic stocks have recently been punished by the market. The flip-side is that many well-capitalized companies now offer spectacular value propositions.
Gold price in striking distance of $1,800 following U.S. ISM data
The gold market remains within striking distance of $1,800 an ounce as activity in the U.S. manufacturing sector hold steady in November.
Ketamine Wellness Centers (KWC) Announces Plans to Expand Operations into Salt Lake City and Reno
Delic Holding Corp's subsidiary, Ketamine Wellness Centers, is planning to open two new clinics, in Salt Lake City, Utah
Gold prices holding gains as U.S. ADP shows 534K jobs gains in November
The gold market is holding on to modest gains Wednesday even as the private sector labor market continues to improve, according to the latest report from private-sector payrolls processor ADP.
UBS launches digital gold trading
This is the first bank in the country to do so, broadening the traditional safe-haven asset's availability to retail customers.
Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network
Novamind expands its treatment footprint via a new partnership with Uruguay-based Bienstar Wellness.
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
Compass Pathways provides further details on its Phase IIb results for the treatment of Treatment Resistant Depression, including reporting of additional "patient improvements".
Albert Labs (CSE: ABRT) Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing
UK-based Albert Labs receives conditional approval from the Canadian Securities Exchange (CSE) to commence trading under the symbol "ABRT". Trading expected to commence in early 2022.
Gold prices push to session highs
The gold market is holding at session highs above $1,800 an ounce.
Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress
Cybin seeks FDA approval for a new Phase 2 clinical trial aimed at treating "distress" among frontline healthcare practitioners.
